SCHEMBL3136643

SCHEMBL3136643

CC(C)(C)c1ccc(S(OS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)(c2ccccc2)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 6/20 0.43
▸ HSD17B3 P37058 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ UQCRB P14927 1/20 0.37
▸ HSD17B2 P37059 1/20 0.37
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA13 Q8N1Q1 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ RORA P35398 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KEAP1 Q14145 1/20 0.35
▸ NFE2L2 Q16236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2898480 1.00 HSD11B1 (0.43) HSD11B1HSD17B3ALDH1A1NPC1RECQL
SCHEMBL5412880 0.94 ALDH1A1 (0.44) HSD11B1HSD17B3ALDH1A1NPC1RECQL
SCHEMBL3136601 0.87 HSD11B1 (0.40) HSD11B1ALDH1A1CA1CA2CA12
SCHEMBL3127186 0.87 HSD11B1 (0.40) HSD11B1ALDH1A1CA1CA2CA12
SCHEMBL384539 0.86 CA1 (0.46) ALDH1A1CA1CA2CA12CA7
SCHEMBL2634260 0.85 HSD11B1 (0.53) HSD11B1HSD17B3ALDH1A1NPC1RECQL
SCHEMBL451539 0.85 HSD11B1 (0.53) HSD11B1HSD17B3ALDH1A1NPC1RECQL
SCHEMBL3693053 0.84 HSD11B1 (0.50) HSD11B1HSD17B3ALDH1A1NPC1RECQL
SCHEMBL3132778 0.84 HTT (0.41) ALDH1A1RECQLCA1CA2CA12
SCHEMBL3135497 0.84 HTT (0.41) ALDH1A1RECQLCA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1676835-B1 PROCESS FOR PRODUCING TRIARYLSULFONIUM SALT WAKO PURE CHEM IND LTD (JP) 2014-12-10 — — EP disclosed
US-7642368-B2 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-01-05 — — US disclosed
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2007-04-12 — — US disclosed
EP-1676835-A1 PROCESS FOR PRODUCING TRIARYLSULFONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2006-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid ARSA, HAO2, HAO1 HSD11B1 718/4885HSD17B3 1776/4885ALDH1A1 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback